Page last updated: 2024-08-23

tetrahydrocannabivarin 9 and Epilepsy

tetrahydrocannabivarin 9 has been researched along with Epilepsy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Friedman, D; Gaston, TE1
Bevan, SA; Hill, AJ; Jones, NA; Smith, I; Stephens, GJ; Weston, SE; Whalley, BJ; Williams, CM; Williamson, EM1

Reviews

1 review(s) available for tetrahydrocannabivarin 9 and Epilepsy

ArticleYear
Pharmacology of cannabinoids in the treatment of epilepsy.
    Epilepsy & behavior : E&B, 2017, Volume: 70, Issue:Pt B

    Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Epilepsy; Humans; Receptor, Cannabinoid, CB1; Treatment Outcome

2017

Other Studies

1 other study(ies) available for tetrahydrocannabivarin 9 and Epilepsy

ArticleYear
Δ⁹-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats.
    Epilepsia, 2010, Volume: 51, Issue:8

    Topics: Animals; Cerebral Cortex; Competitive Bidding; Disease Models, Animal; Dronabinol; Drug Interactions; Epilepsy; Evoked Potentials; Female; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Male; Pentylenetetrazole; Phosphorus Isotopes; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant

2010